Retina Gallery ~ Full Sized Retina Images

Myopic CNVM - lacquer crack - recurrence 6 years later 31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 17231 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 21731 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 19531 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 17531 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 20931 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 19231 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 20131 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 19931 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 19631 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 19831 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 16631 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 16131 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 18231 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 16831 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 18331 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 18731 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 19131 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 19731 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 22631 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 20431 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 21631 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 17631 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 22131 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 19331 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 15731 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 16231 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 18231 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 19031 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 17131 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 18131 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 17131 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 18831 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 17831 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 19531 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 21231 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 18431 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 18831 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 18231 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 22031 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 19831 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
40 faili 1 lehel

31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.